These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


243 related items for PubMed ID: 12032741

  • 1. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial.
    Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T.
    Int J Obes Relat Metab Disord; 2002 May; 26(5):593-604. PubMed ID: 12032741
    [Abstract] [Full Text] [Related]

  • 2. Multinutrient supplement containing ephedra and caffeine causes weight loss and improves metabolic risk factors in obese women: a randomized controlled trial.
    Hackman RM, Havel PJ, Schwartz HJ, Rutledge JC, Watnik MR, Noceti EM, Stohs SJ, Stern JS, Keen CL.
    Int J Obes (Lond); 2006 Oct; 30(10):1545-56. PubMed ID: 16552410
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis.
    Shekelle PG, Hardy ML, Morton SC, Maglione M, Mojica WA, Suttorp MJ, Rhodes SL, Jungvig L, Gagné J.
    JAMA; 2003 Mar 26; 289(12):1537-45. PubMed ID: 12672771
    [Abstract] [Full Text] [Related]

  • 4. An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.
    Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL.
    Int J Obes Relat Metab Disord; 2001 Mar 26; 25(3):316-24. PubMed ID: 11319627
    [Abstract] [Full Text] [Related]

  • 5. Effect of a dietary herbal supplement containing caffeine and ephedra on weight, metabolic rate, and body composition.
    Greenway FL, De Jonge L, Blanchard D, Frisard M, Smith SR.
    Obes Res; 2004 Jul 26; 12(7):1152-7. PubMed ID: 15292480
    [Abstract] [Full Text] [Related]

  • 6. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial.
    McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM.
    JAMA; 2004 Jan 14; 291(2):216-21. PubMed ID: 14722148
    [Abstract] [Full Text] [Related]

  • 7. A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment.
    Coffey CS, Steiner D, Baker BA, Allison DB.
    Int J Obes Relat Metab Disord; 2004 Nov 14; 28(11):1411-9. PubMed ID: 15356670
    [Abstract] [Full Text] [Related]

  • 8. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure.
    Vukovich MD, Schoorman R, Heilman C, Jacob P, Benowitz NL.
    Clin Exp Pharmacol Physiol; 2005 Nov 14; 32(1-2):47-53. PubMed ID: 15730434
    [Abstract] [Full Text] [Related]

  • 9. [Ephedrine and ephedra in weight loss products and other preparations].
    van der Hooft CS, Stricker BH.
    Ned Tijdschr Geneeskd; 2002 Jul 13; 146(28):1335-6. PubMed ID: 12148223
    [Abstract] [Full Text] [Related]

  • 10. Effect of a multicomponent, ephedra-containing dietary supplement (Metabolife 356) on Holter monitoring and hemostatic parameters in healthy volunteers.
    Gardner SF, Franks AM, Gurley BJ, Haller CA, Singh BK, Mehta JL.
    Am J Cardiol; 2003 Jun 15; 91(12):1510-3, A9. PubMed ID: 12804749
    [No Abstract] [Full Text] [Related]

  • 11. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
    Kalman D, Incledon T, Gaunaurd I, Schwartz H, Krieger D.
    Int J Obes Relat Metab Disord; 2002 Oct 15; 26(10):1363-6. PubMed ID: 12355332
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of treatment with an ephedrine/caffeine mixture. The first double-blind placebo-controlled pilot study in adolescents.
    Molnár D, Török K, Erhardt E, Jeges S.
    Int J Obes Relat Metab Disord; 2000 Dec 15; 24(12):1573-8. PubMed ID: 11126208
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of long-term treatment with ephedrine, caffeine and an ephedrine/caffeine mixture.
    Toubro S, Astrup AV, Breum L, Quaade F.
    Int J Obes Relat Metab Disord; 1993 Feb 15; 17 Suppl 1():S69-72. PubMed ID: 8384186
    [Abstract] [Full Text] [Related]

  • 14. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial.
    Astrup A, Breum L, Toubro S, Hein P, Quaade F.
    Int J Obes Relat Metab Disord; 1992 Apr 15; 16(4):269-77. PubMed ID: 1318281
    [Abstract] [Full Text] [Related]

  • 15. Effect of herbal Ephedra sinica and Evodia rutaecarpa on body composition and resting metabolic rate: a randomized, double-blind clinical trial in Korean premenopausal women.
    Kim HJ, Park JM, Kim JA, Ko BP.
    J Acupunct Meridian Stud; 2008 Dec 15; 1(2):128-38. PubMed ID: 20633465
    [Abstract] [Full Text] [Related]

  • 16. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.
    Haller CA, Jacob P, Benowitz NL.
    Clin Pharmacol Ther; 2002 Jun 15; 71(6):421-32. PubMed ID: 12087345
    [Abstract] [Full Text] [Related]

  • 17. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent.
    Greenway FL.
    Obes Rev; 2001 Aug 15; 2(3):199-211. PubMed ID: 12120105
    [Abstract] [Full Text] [Related]

  • 18. The effect of ephedrine plus caffeine on plasma lipids and lipoproteins during a 4.2 MJ/day diet.
    Buemann B, Marckmann P, Christensen NJ, Astrup A.
    Int J Obes Relat Metab Disord; 1994 May 15; 18(5):329-32. PubMed ID: 8061726
    [Abstract] [Full Text] [Related]

  • 19. Concentrations of ephedra alkaloids and caffeine in commercial dietary supplements.
    Haller CA, Duan M, Benowitz NL, Jacob P.
    J Anal Toxicol; 2004 Apr 15; 28(3):145-51. PubMed ID: 15107143
    [Abstract] [Full Text] [Related]

  • 20. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations.
    Haller CA, Jacob P, Benowitz NL.
    Clin Pharmacol Ther; 2005 Jun 15; 77(6):560-71. PubMed ID: 15961987
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.